It anchors a broader, supervised plan that also addresses nutrition, activity, and the metabolic factors driving your results
Based on what is known about its drug class and the enrollment criteria of clinical trials, retatrutide should be avoided in the following cases: The side effects most commonly linked to retatrutide in clinical trials involved the gastrointestinal tract
Food cravings often diminish dramatically in week one, making it easier to stick to a lower-calorie diet without the psychological struggle of traditional dieting
Anti-inflammatory effects via NF-kB modulation Inflammation and weight loss have a complicated relationship
After the initial 4 weeks, your dose increases by 2.5mg every 4 weeks until you reach your maintenance dose typically 5mg, 10mg, or 15mg depending on how you respond and what you can tolerate